Literature DB >> 22153299

Characterization of a monoclonal anti-capsid antibody that cross-reacts with three major primate lentivirus lineages.

Brigitte E Sanders-Beer1, Magdalena Eschricht, Janna Seifried, Vanessa M Hirsch, Jonathan S Allan, Stephen Norley.   

Abstract

Mouse monoclonal antibodies with varying specificities against the Gag capsid of simian and human immunodeficiency virus (SIV/HIV) were generated by immunizing mice with whole inactivated SIVagmTYO-1. Monoclonal antibody AG3.0 showed the broadest reactivity recognizing the Gag capsid protein (p24-27) and Gag precursors p38, p55, and p150 of HIV-1, HIV-2, SIVmac, and SIVagm. Using overlapping peptides, the AG3.0 epitope was mapped in capsid to a sequence (SPRTLNA) conserved among HIV-1, HIV-2, SIVrcm, SIVsm/mac, and SIVagm related viruses. Because of its broad cross-reactivity, AG3.0 was used to develop an antigen capture assay with a lower detection limit of 100 pg/ml HIV-1 Gag p24. Interestingly, AG3.0 was found to have a faster binding on/off rate for SIVagmVer and SIVmac Gag than for SIVagmSab Gag, possibly due to differences outside the SPRTLNA motif. In addition, the ribonucleic acid (RNA) coding for AG3.0 was sequenced to facilitate the development of humanized monoclonal antibodies.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22153299      PMCID: PMC6324184          DOI: 10.1016/j.virol.2011.11.003

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  78 in total

1.  Three-dimensional structure of the M-MuLV CA protein on a lipid monolayer: a general model for retroviral capsid assembly.

Authors:  Barbie K Ganser; Anchi Cheng; Wesley I Sundquist; Mark Yeager
Journal:  EMBO J       Date:  2003-06-16       Impact factor: 11.598

2.  Functional surfaces of the human immunodeficiency virus type 1 capsid protein.

Authors:  Uta K von Schwedler; Kirsten M Stray; Jennifer E Garrus; Wesley I Sundquist
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

3.  Characterization of novel simian immunodeficiency viruses from red-capped mangabeys from Nigeria (SIVrcmNG409 and -NG411).

Authors:  B E Beer; B T Foley; C L Kuiken; Z Tooze; R M Goeken; C R Brown; J Hu; M St Claire; B T Korber; V M Hirsch
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

4.  Partial molecular characterization of two simian immunodeficiency viruses (SIV) from African colobids: SIVwrc from Western red colobus (Piliocolobus badius) and SIVolc from olive colobus (Procolobus verus).

Authors:  Valerie Courgnaud; Pierre Formenty; Chantal Akoua-Koffi; Ronald Noe; Christophe Boesch; Eric Delaporte; Martine Peeters
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

5.  Simian immunodeficiency virus replicates to high levels in naturally infected African green monkeys without inducing immunologic or neurologic disease.

Authors:  S R Broussard; S I Staprans; R White; E M Whitehead; M B Feinberg; J S Allan
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

6.  Frequency and function of HIV-specific CD8(+) T cells.

Authors:  S A Migueles; M Connors
Journal:  Immunol Lett       Date:  2001-11-01       Impact factor: 3.685

7.  Simian immunodeficiency virus (SIV) from sun-tailed monkeys (Cercopithecus solatus): evidence for host-dependent evolution of SIV within the C. lhoesti superspecies.

Authors:  B E Beer; E Bailes; R Goeken; G Dapolito; C Coulibaly; S G Norley; R Kurth; J P Gautier; A Gautier-Hion; D Vallet; P M Sharp; V M Hirsch
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

8.  Characterization of a novel simian immunodeficiency virus from guereza colobus monkeys (Colobus guereza) in Cameroon: a new lineage in the nonhuman primate lentivirus family.

Authors:  V Courgnaud; X Pourrut; F Bibollet-Ruche; E Mpoudi-Ngole; A Bourgeois; E Delaporte; M Peeters
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

9.  Characterization and comparison of recombinant simian immunodeficiency virus from drill (Mandrillus leucophaeus) and mandrill (Mandrillus sphinx) isolates.

Authors:  Jinjie Hu; William M Switzer; Brian T Foley; David L Robertson; Robert M Goeken; Bette T Korber; Vanessa M Hirsch; Brigitte E Beer
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

10.  Foci of endemic simian immunodeficiency virus infection in wild-living eastern chimpanzees (Pan troglodytes schweinfurthii).

Authors:  Mario L Santiago; Magdalena Lukasik; Shadrack Kamenya; Yingying Li; Frederic Bibollet-Ruche; Elizabeth Bailes; Martin N Muller; Melissa Emery; David A Goldenberg; Jeremiah S Lwanga; Ahidjo Ayouba; Eric Nerrienet; Harold M McClure; Jonathan L Heeney; David P Watts; Anne E Pusey; D Anthony Collins; Richard W Wrangham; Jane Goodall; John F Y Brookfield; Paul M Sharp; George M Shaw; Beatrice H Hahn
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

View more
  5 in total

1.  4-Quinolone alkaloids from Melochia odorata.

Authors:  Raquel C Jadulco; Christopher D Pond; Ryan M Van Wagoner; Michael Koch; Osia G Gideon; Teatulohi K Matainaho; Pius Piskaut; Louis R Barrows
Journal:  J Nat Prod       Date:  2014-01-07       Impact factor: 4.050

2.  Access of HIV-2 to CD169-dependent dendritic cell-mediated trans infection pathway is attenuated.

Authors:  Suzanne D G Kijewski; Hisashi Akiyama; Amin Feizpour; Caitlin M Miller; Nora-Guadalupe P Ramirez; Björn M Reinhard; Suryaram Gummuluru
Journal:  Virology       Date:  2016-08-11       Impact factor: 3.616

3.  Impact of naturally occurring amino acid variations on the detection of HIV-1 p24 in diagnostic antigen tests.

Authors:  Beatrice N Vetter; Vanessa Orlowski; Christoph Niederhauser; Louise Walter; Jörg Schüpbach
Journal:  BMC Infect Dis       Date:  2015-10-29       Impact factor: 3.090

4.  Analysis of the functional compatibility of SIV capsid sequences in the context of the FIV gag precursor.

Authors:  César A Ovejero; José L Affranchino; Silvia A González
Journal:  PLoS One       Date:  2017-05-05       Impact factor: 3.240

5.  Vpx enhances innate immune responses independently of SAMHD1 during HIV-1 infection.

Authors:  Oya Cingöz; Nicolas D Arnow; Mireia Puig Torrents; Norbert Bannert
Journal:  Retrovirology       Date:  2021-02-09       Impact factor: 4.602

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.